Differential effects of calcium-dependent and calcium-independent phospholipase A 2 inhibitors on kainate-induced neuronal injury in rat hippocampal slices

Dennis, 1997, The growing phospholipase A2 superfamily of signal transduction enzymes, Trends Biochem. Sci., 22, 1, 10.1016/S0968-0004(96)20031-3

Ackermann, 1995, Mammalian calcium-independent phospholipase A2, Biochim. Biophys. Acta Lipids Lipid Metab., 1259, 125, 10.1016/0005-2760(95)00143-Z

Murakami, 1997, Regulatory functions of phospholipase A2, Crit. Rev. Immunol., 17, 225, 10.1615/CritRevImmunol.v17.i3-4.10

Tischfield, 1997, A reassessment of the low molecular weight phospholipase A2 gene family in mammals, J. Biol. Chem., 272, 17247, 10.1074/jbc.272.28.17247

Farooqui, 1997, Phospholipase A2 and its role in brain tissue, J. Neurochem., 69, 889, 10.1046/j.1471-4159.1997.69030889.x

Mattson, 1998, Modification of ion homeostasis by lipid peroxidation, Trends Neurosci., 21, 53, 10.1016/S0166-2236(97)01188-0

Kim, 1995, Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures, Biochem. J., 310, 83, 10.1042/bj3100083

Farooqui, 1994, Excitotoxicity and neurological disorders, Int. Rev. Neurobiol., 36, 267, 10.1016/S0074-7742(08)60306-2

Ong, 1999, Distribution of cytoplasmic phospholipase A2 in the normal rat brain, J. Hirnforsch., 39, 391

Farooqui, 2000, Brain cytosolic phospholipase A2, Neuroscientist, 6, 169, 10.1177/107385840000600308

Ong, 1999, Immunocytochemical localization of cPLA2 in rat and monkey spinal cord, J. Mol. Neurosci., 12, 123, 10.1007/BF02736926

Owada, 1994, Molecular cloning of rat cDNA for cytosolic phospholipase A2 and the increased gene expression in the dentate gyrus following transient forebrain ischemia, Mol. Brain Res., 25, 364, 10.1016/0169-328X(94)90174-0

Clemens, 1996, Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat, Stroke, 27, 527, 10.1161/01.STR.27.3.527

Bonventre, 1999, The 85-kD cytosolic phospholipase A2 knockout mouse, J. Am. Soc. Nephrol., 10, 404, 10.1681/ASN.V102404

Walton, 1997, Prostaglandin H synthase-2 and cytosolic phospholipase A2 in the hypoxic-ischemic brain, Mol. Brain Res., 50, 165, 10.1016/S0169-328X(97)00181-2

Stephenson, 1996, Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer’s disease brain, Neurobiol. Dis., 3, 51, 10.1006/nbdi.1996.0005

Stephenson, 1999, Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration, Glia, 27, 110, 10.1002/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C

Sandhya, 1998, A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions, Brain Res., 788, 223, 10.1016/S0006-8993(97)01552-7

Ong, 2000, Changes in glutathione in the hippocampus of rats injected with kainate, Exp. Brain Res., 132, 510, 10.1007/s002210000347

Ong, 2000, Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus, Free Radic. Biol. Med., 28, 1214, 10.1016/S0891-5849(00)00238-0

Ginsburg, 1993, Killing of endothelial cells and release of arachidonic acid, Inflammation, 17, 295, 10.1007/BF00918992

Hope, 1993, Secretory phospholipase A2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A2, Agents Actions, 39, C39, 10.1007/BF01972714

Dubin, 1982, Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys, Fert. Steril., 38, 735, 10.1016/S0015-0282(16)46703-8

Estevez, 1997, The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion, Brain Res., 752, 203, 10.1016/S0006-8993(96)01450-3

Lu, X. R.; Ong, W. Y.; Halliwell, B. The phospholipase A2 inhibitor quinacrine prevents increased immunoreactivity to cytoplasmic phospholipase A2 (cPLA2) and hydroxynonenal (HNE) in neurons of the lateral septum following fimbria-fornix transection. Exp. Brain Res. In Press.

Street, 1993, Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2, Biochemistry, 32, 5935, 10.1021/bi00074a003

Trimble, 1993, NMR structural studies of the tight complex between a trifluoromethyl ketone inhibitor and the 85-kDa human phospholipase A2, Biochemistry, 32, 12560, 10.1021/bi00210a002

Gronich, 1994, Interleukin 1α causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells, J. Clin. Invest., 93, 1224, 10.1172/JCI117076

Kim, 1998, Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2, Biochem. Pharmacol., 55, 975, 10.1016/S0006-2952(97)00613-8

Ackermann, 1995, Inhibition of macrophage Ca2+-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones, J. Biol. Chem., 270, 445, 10.1074/jbc.270.1.445

Hazen, 1990, Purification and characterization of canine myocardial cytosolic phospholipase A2, J. Biol. Chem., 265, 10622, 10.1016/S0021-9258(18)86992-7

Zupan, 1993, Structural determinants of haloenol lactone-mediated suicide inhibition of canine myocardial calcium-independent phospholipase A2, J. Med. Chem., 36, 95, 10.1021/jm00053a012

Hirashima, 1992, Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol, J. Neurochem., 59, 708, 10.1111/j.1471-4159.1992.tb09426.x

Farooqui, 1999, Inhibitors of intracellular phospholipase A2 activity, Brain Res. Bull., 49, 139, 10.1016/S0361-9230(99)00027-1

Stoppini, 1991, A simple method for organotypic cultures of nervous tissue, J. Neurosci. Methods, 37, 173, 10.1016/0165-0270(91)90128-M

Noraberg, 1999, Markers for neuronal degeneration in organotypic slice cultures, Brain Res. Brain Res. Protoc., 3, 278, 10.1016/S1385-299X(98)00050-6

1995, The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke, N. Engl. J. Med., 333, 1581, 10.1056/NEJM199512143332401

Christou, 2000, Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke, Stroke, 31, 1812, 10.1161/01.STR.31.8.1812

Waeg, 1996, Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins, Free Radic. Res., 25, 149, 10.3109/10715769609149920

Mustonen, 1998, Binding of quinacrine to acidic phospholipids and pancreatic phospholipase A2. Effects on the catalytic activity of the enzyme, Biochemistry, 37, 12051, 10.1021/bi980430q

Chabot, 1998, Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus, Hippocampus, 8, 299, 10.1002/(SICI)1098-1063(1998)8:3<299::AID-HIPO11>3.0.CO;2-W

Bonventre, 1997, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature, 390, 622, 10.1038/37635

Klivenyi, 1998, Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity, J. Neurochem., 71, 2634, 10.1046/j.1471-4159.1998.71062634.x